King Pharmaceuticals KG Net Change in Cash
Net Change in Cash at other companies
Other financials
Where this comes from
Reported directly by King Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.
The official record: King Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about King Pharmaceuticals's net change in cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is King Pharmaceuticals's net change in cash?
- King Pharmaceuticals (KG) reported net change in cash of $36.83M in Q1 2026.
- How has King Pharmaceuticals's net change in cash changed year-over-year?
- King Pharmaceuticals's net change in cash increased by 4304.5% year-over-year, from -$876K to $36.83M.
- What does net change in cash mean?
- Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.